Administration guidelines for intraperitoneal chemotherapy for ovarian cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Ovarian cancer has a unique pattern of spread, with the peritoneal cavity being the primary site of disease. Intraperitoneal delivery of chemotherapeutic agents allows for a higher concentration of drug for a more prolonged period of time at the major site of disease, providing a rationale for its use in ovarian cancer. This approach is supported by multiple clinical trials demonstrating an improved outcome for ovarian cancer patients who receive intraperitoneal chemotherapy. This chapter will address issues critical to the administration of intraperitoneal chemotherapy in ovarian cancer including selection of appropriate patients, the fundamentals of intraperitoneal chemotherapy administration, as well as practical guidelines for trouble-shooting commonly encountered problems.

Original languageEnglish (US)
Title of host publicationIntraperitoneal Therapy for Ovarian Cancer
PublisherSpringer Berlin Heidelberg
Pages89-94
Number of pages6
ISBN (Print)9783642121296
DOIs
StatePublished - Dec 1 2010

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Administration guidelines for intraperitoneal chemotherapy for ovarian cancer'. Together they form a unique fingerprint.

Cite this